EUCTR2017-002153-11-FR进行中（未招募）1 期
ong-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular GeneTherapy in the RESCUE or REVERSE Phase III Clinical Trials - GS010 long term follow up
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Subject was treated with GS010 IVT injection in either of the RESCUE or REVERSE Phase III clinical studies.
- •2. Subject of legal consent age has provided informed consent; subjects that are not of legal consent age have undergone their country-approved clinical trial enrollment consent process.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Subject is unwilling or unable to comply with the protocol requirements.
- •2. Subject has any medical or psychological condition that, in the opinion of the Investigator, may compromise his or her safe participation in the study.
- •3. Subject is taking or intending to take idebenone during the long-term follow-up study period.
研究者
相似试验
进行中（未招募）
1 期
ong-term Follow-up of ND4 LHON Subjects Treated With GS010EUCTR2017-002153-11-GBGENSIGHT BIOLOGICS76
进行中（未招募）
1 期
ong-term Follow-up of ND4 LHON Subjects Treated With GS010eber Hereditary Optic Neuropathy due to mutations in the mitochondrialNADH Dehydrogenase 4 geneMedDRA version: 20.1Level: LLTClassification code 10062951Term: Leber's hereditary optic atrophy neuropathySystem Organ Class: 100000004850EUCTR2017-002153-11-DEGENSIGHT BIOLOGICS76
进行中（未招募）
1 期
ong-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trialseber Hereditary Optic Neuropathy due to mutations in the mitochondrial NADH Dehydrogenase 4 geneMedDRA version: 20.1Level: LLTClassification code 10062951Term: Leber's hereditary optic atrophy neuropathySystem Organ Class: 100000004850EUCTR2017-002153-11-ITGENSIGHT BIOLOGICS76
进行中（未招募）
1 期
A long-term follow-up study for patients treated with Galapagos CAR T cell therapiesRelapsed/refractory B-Cell non-Hodgkin lymphoma, Relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Relapsed/refractory multiple myelomaMedDRA version: 21.0Level: LLTClassification code: 10051812Term: Small cell lymphocytic lymphoma Class: 10029104MedDRA version: 20.0Level: HLGTClassification code: 10025320Term: Lymphomas non-Hodgkin's B-cell Class: 10029104MedDRA version: 21.0Level: LLTClassification code: 10008976Term: Chronic lymphocytic leukemia Class: 10029104CTIS2023-510173-34-00Galapagos300
已完成
不适用
ong-term follow-up and prognosis of patients with ulnar neuropathy at the elbow in which the electrodiagnostic study shows a motor conduction block of more than 50%nerve at elbowulnar neuropathy10034606NL-OMON29769Sint Elisabeth Ziekenhuis80